WARD ROUND PARTICIPATION

- INTRODUCTION -

Prepared by: Dr. C. Suhas Reddy

Dept. of Pharmacy Practice
 INDEX
 INTRODUCTION
 DEFINITION

 CLINICAL PHARMACIST – GOALS IN W-R-P

 WARD ROUNDS IN INDIAN SCENARIO

 TYPES OF WARD ROUNDS

 PRE-WARD ROUND PREPARATIONS

 INTERVENTIONS DURING WARD ROUNDS

 COMMUNICTION IN WARD ROUNDS

 WARD ROUND FOLLOWUP

 INTRODUCTION
 1990’S- pharmacy profession started moving away
from the traditional role of a compounder preparing
and selling medications to that of a
pharmacy practitioner providing patient-oriented
health services.
 ‘pharmaceutical care’ concept described by
Hepler and Strand empowers pharmacists
with greater responsibility and accountability
inpatient care.
 Pharmaceutical care  is the process through
which a pharmacist co-operates with a patient
and other professionals in designing,
implementing and monitoring a therapeutic
plan that will produce specific health
outcomes for the patient.
The fundamental responsibility of a pharmacist

every patient receives the most

appropriate evidence based treatment in
the most convenient and cost-effective
form at the right time.
 This involves influencing medicine use
decisions not only by patients, but also by
healthcare professionals.

 The knowledge and skills of pharmacists for

combining therapeutic, pharmacological and
pharmaceutical data can help ensure optimal
patient outcome.
 Retrospective prescriptions review has shown
greater results in patient better care.

 If inputs can given at the time of prescribing –

improve quality & safety of medicine
 DEFINITION

 A ward round is a visit made by a medical

practitioner, alone or with a team of health
professionals and medical students, to
hospital inpatients at their bedside to
review and follow-up progress in their
health.
  Psychiatry - round is conducted every day to
review the progress of each inpatient,
although more than one is not uncommon. In
certain practice settings such as
 Pharmacist participation in ward rounds (UK, USA,
CANADA,AUSTRALIA) in 1970’s – reduced –
 decreased adverse drug events,

 improved patient care,

 reduced length of hospital stay and

 reduced healthcare costs

 CLINICAL PHARMACIST GOALS IN W-R-P

Gain an improved understanding of



the patient’s clinical status and

progress, current planned
investigations and therapeutic goals
 CLINICAL PHARMACIST GOALS IN W-R-P

Provide relevant information on



various aspects of the patient’s drug

therapy, such as pharmacology,
pharmacokinetics, drug availability,
cost, drug interactions and adverse
Reactions
 CLINICAL PHARMACIST GOALS IN W-R-P

Optimise therapeutic management by



influencing drug therapy selection,

implementation, monitoring and follow-up

 Investigate unusual drug orders or doses

 CLINICAL PHARMACIST GOALS IN W-R-P

 Assimilate additional information about the

patient such as co-morbidities, medication
compliance or complementary and alternative
medicine (for example herbal remedies) use
that might be relevant to their management
 CLINICAL PHARMACIST GOALS IN W-R-P

Detect adverse drug reactions and



drug interactions

Participate
 in patient discharge
planning
 Pharmacist’s chance
 Teaching hospital – doctors - CME

 Non-teaching hospital – doctors no CME –

pharmacist evidence based
pharmacotherapy / Management
INDEX
INDEX
INDEX
INDEX
INDEX
INDEX
INDEX
INDEX